CYP8B1: A Cholesterol-Binding Enzyme (G1582)

Target Name: CYP8B1

NCBI ID: G1582

CYP8B1

CYP8B1: A Cholesterol-Binding Enzyme

CYP8B1, also known as 7alpha-hydroxycholest-4-en-3-one,NADPH:oxygen oxidoreductase (12alpha-hydroxylating), is a enzyme that plays a crucial role in the metabolism of cholesterol. Cholesterol is a natural substance found in the blood that is essential for the normal functioning of the body. However, cholesterol levels can become too high or too low, which can cause health problems such as heart disease and stroke. The liver is responsible for regulating cholesterol levels, but it can sometimes become overwhelmed by the amount of cholesterol it needs to process. This can lead to the liver becoming less effective at removing cholesterol from the blood, which can cause levels to rise.

CYP8B1 is an enzyme that helps the liver remove cholesterol from the blood by converting it into a less harmful form. It is found in all tissues throughout the body and is encoded by the gene CYP8B1. It is a potent enzyme that is involved in the metabolism of both low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol. LDL cholesterol is considered \"bad\" cholesterol because it can contribute to the development of heart disease and stroke. HDL cholesterol, on the other hand, is considered \"good\" cholesterol because it helps to protect against heart disease and stroke.

CYP8B1 is a critical enzyme in the cholesterol metabolism because it converts the potentially harmful 7alpha-hydroxycholest-4-en-3-one (7-OH) cholesterol into 12alpha-hydroxylated cholesterol (12-OH cholesterol). 7-OH cholesterol is a byproduct of the metabolism of cholesterol, and it has been shown to be associated with an increased risk of heart disease and stroke. By converting 7-OH cholesterol into 12-OH cholesterol, CYP8B1 helps to reduce the amount of potentially harmful cholesterol in the blood.

CYP8B1 is also involved in the metabolism of other compounds, including drugs that are used to treat heart disease and stroke. For example, some drugs used to treat heart disease and stroke, such as statins, work by inhibiting the production of cholesterol in the liver. In order for these drugs to work, they need to be taken by the liver, and CYP8B1 is involved in the metabolism of the drugs that are used to increase the levels of cholesterol in the liver.

CYP8B1 is also a potential drug target for researchers because of its role in the metabolism of cholesterol. By targeting CYP8B1, researchers can study how the liver processes cholesterol and how that process can be affected by different factors, such as the levels of cholesterol in the blood. This information can be used to develop new treatments for heart disease and stroke.

In addition to its role in the metabolism of cholesterol, CYP8B1 is also involved in the regulation of other processes in the body. For example, it is involved in the metabolism of toxins and other substances that are harmful to the body. It also plays a role in the regulation of the immune system, which is important for protecting the body against infection and disease.

CYP8B1 is a versatile enzyme that is involved in a wide range of processes in the body. Its role in the metabolism of cholesterol is just one example of its many functions. Researchers are continuing to study the role of CYP8B1 in the body and its potential as a drug target. By understanding more about how CYP8B1 works, researchers can develop new treatments for heart disease and stroke that can help to improve the health and well-being of people around the world.

Protein Name: Cytochrome P450 Family 8 Subfamily B Member 1

Functions: A cytochrome P450 monooxygenase involved in primary bile acid biosynthesis. Catalyzes the 12alpha-hydroxylation of 7alpha-hydroxy-4-cholesten-3-one, an intermediate metabolite in cholic acid biosynthesis (PubMed:10051404). Controls biliary balance of cholic acid and chenodeoxycholic acid, ultimately regulating the intestinal absorption of dietary lipids (By similarity). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH--hemoprotein reductase) (By similarity)

The "CYP8B1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYP8B1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets